Insulin aspart, recombinant Subcutaneous and Reglan Tablets
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Reglan Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: metoclopramide
Brand name: Metozolv ODT, Reglan
Synonyms: Metoclopramide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Regonol
- Insulin aspart, recombinant Subcutaneous-Regorafenib
- Insulin aspart, recombinant Subcutaneous-Reguloid
- Insulin aspart, recombinant Subcutaneous-Rejuva-A Topical
- Insulin aspart, recombinant Subcutaneous-Relador Pak Plus
- Insulin aspart, recombinant Subcutaneous-Relafen
- Reglan Tablets-Insulin degludec
- Reglan Tablets-Insulin Degludec (U-100) Prefilled Pens
- Reglan Tablets-Insulin Degludec (U-100) Vials
- Reglan Tablets-Insulin Degludec (U-200) Prefilled Pens
- Reglan Tablets-Insulin degludec and liraglutide
- Reglan Tablets-Insulin degludec and liraglutide Subcutaneous